Zhong Nanshan's Team Finds 71% of Lung Nodule Patients Are Non-Smokers

A research team led by renowned Chinese respiratory disease expert Zhong Nanshan has reported a finding that is drawing attention to lung health and early screening:71% of patients with detected lung nodules in the team's research were non-smokers.

The finding highlights a growing medical concern that lung health cannot be assessed solely on the basis of smoking history. While smoking remains an established major risk factor for lung cancer, the presence of lung nodules is also being observed among people who have never smoked.

Lung nodules are small, rounded or irregular areas of increased density found in the lungs, most commonly identified through chest CT scans. Most lung nodules are not cancerous, but some can be associated with early-stage lung cancer. Determining whether a nodule is benign or malignant generally requires physicians to consider multiple factors rather than relying on a single characteristic.

The research involving Zhong's team adds to growing interest in the characteristics of lung nodules among non-smokers. The reported 71% figure suggests that a substantial proportion of people undergoing evaluation for lung nodules may have no history of smoking.

The finding is particularly relevant in China, where lung cancer remains a major public health concern. It also comes as medical researchers and hospitals increasingly focus on early detection and more precise assessment of pulmonary abnormalities.

Zhong Nanshan, an academician of the Chinese Academy of Engineering, has spent decades working in respiratory medicine. His team has been involved in research and clinical work covering respiratory diseases, lung cancer screening and early intervention. In 2026, Zhong emphasized at the Nanshan Respiratory Health Forum that artificial intelligence is becoming increasingly important in areas including lung nodule diagnosis and lung cancer screening.

The growing use of CT imaging has also made the detection of small pulmonary nodules more common. As imaging technology becomes more sensitive, doctors can identify abnormalities that may previously have gone undetected.

However, the discovery of a lung nodule does not automatically mean that a patient has cancer. Medical professionals typically evaluate factors such as nodule size, shape, density, location, changes over time and the patient's overall clinical history. Follow-up imaging or additional diagnostic procedures may be recommended depending on the circumstances.

The finding that many lung nodule patients are non-smokers therefore does not mean that smoking is unrelated to lung cancer. Rather, it underscores the complexity of lung disease and the importance of considering multiple risk factors.

For non-smokers, the finding may also serve as a reminder that being a non-smoker does not eliminate the possibility of developing pulmonary abnormalities. Other factors, including environmental exposures, air pollution, occupational exposure, family history and biological factors, may also be relevant, although their individual effects vary and should be assessed by medical professionals.

Researchers are increasingly exploring how artificial intelligence and advanced imaging can help distinguish potentially high-risk nodules from benign lesions. More accurate assessment could help reduce unnecessary invasive procedures while allowing suspicious lesions to be investigated at an earlier stage.

The reported findings from Zhong Nanshan's team therefore add another dimension to the discussion surrounding lung cancer prevention and screening. Rather than focusing exclusively on smoking history, modern respiratory medicine is increasingly moving toward comprehensive risk assessment and individualized screening strategies.

For the public, experts generally emphasize that the discovery of a lung nodule should not immediately cause panic. At the same time, individuals should not ignore medical follow-up recommendations. Whether a nodule requires observation, further testing or treatment depends on its specific characteristics and the patient's clinical situation.

As research into lung nodules continues, the combination of advanced imaging, artificial intelligence and clinical expertise could provide doctors with more effective tools for identifying high-risk cases.

The reported71% non-smoking figureserves as a notable reminder that lung health is a complex issue. Smoking cessation remains important for reducing lung cancer risk, but the absence of a smoking history alone cannot determine whether a person is free from lung disease.